1. Home
  2. MSGE vs BEAM Comparison

MSGE vs BEAM Comparison

Compare MSGE & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madison Square Garden Entertainment Corp.

MSGE

Madison Square Garden Entertainment Corp.

HOLD

Current Price

$74.76

Market Cap

3.0B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$27.69

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSGE
BEAM
Founded
2020
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
MSGE
BEAM
Price
$74.76
$27.69
Analyst Decision
Buy
Buy
Analyst Count
7
12
Target Price
$61.00
$50.75
AVG Volume (30 Days)
532.8K
2.7M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.31
EPS
1.59
N/A
Revenue
$942,734,000.00
$24,000.00
Revenue This Year
$10.53
N/A
Revenue Next Year
$6.53
$33.77
P/E Ratio
$46.33
N/A
Revenue Growth
N/A
33.33
52 Week Low
$35.31
$15.60
52 Week High
$82.79
$38.26

Technical Indicators

Market Signals
Indicator
MSGE
BEAM
Relative Strength Index (RSI) 52.07 34.36
Support Level $73.00 $26.96
Resistance Level $82.79 $29.68
Average True Range (ATR) 2.42 2.45
MACD -0.61 -0.95
Stochastic Oscillator 22.39 5.82

Price Performance

Historical Comparison
MSGE
BEAM

About MSGE Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: